Skip to main content
Erschienen in: European Radiology 10/2019

15.03.2019 | Magnetic Resonance

Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis

verfasst von: Yali Qu, Mou Li, Gavin Hamilton, Yingzhen N. Zhang, Bin Song

Erschienen in: European Radiology | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of this meta-analysis was to evaluate the diagnostic accuracy of hepatic magnetic resonance imaging-proton density fat fraction (MRI-PDFF) for the assessment of liver steatosis (LS) with histology as reference standard.

Methods

A systematic literature search was performed to identify pertinent studies. Quality analyses were conducted by Quality Assessment of Diagnostic Accuracy Studies-2. Diagnostic data were extracted and inconsistency index was calculated for LS≥G1, LS≥G2, and LS=G3, respectively. The area under summary receiver operating characteristic curve (AUC) served as the indicator of diagnostic accuracy. The pooled sensitivity and specificity were calculated if threshold effect was absent.

Results

Thirteen studies containing 1100 subjects were included. There was significant threshold effect for LS≥G1. The AUCs for LS≥G1, LS≥G2, and LS=G3 were 0.98 (95% confidence interval (CI) 0.76, 1.00), 0.91 (95% CI 0.89, 0.94), and 0.92 (95% CI 0.89, 0.94), respectively. The pooled sensitivities for LS≥G2 and LS=G3 were 0.83 (95% CI 0.75, 0.88) and 0.79 (95% CI 0.63, 0.90), respectively; the pooled specificities for LS≥G2 and LS=G3 were 0.89 (95% CI 0.84, 0.92) and 0.89 (95% CI 0.84, 0.92), respectively.

Conclusions

MRI-PDFF has high diagnostic accuracy at detecting and grading LS with histology as reference standard, suggesting that MRI-PDFF is able to provide an accurate quantification of LS in clinical trials and patient care.

Key Point

MRI-PDFF is able to provide an accurate quantification of LS in clinical trials and patient care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749CrossRefPubMedPubMedCentral Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313:2263–2273CrossRefPubMed Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313:2263–2273CrossRefPubMed
3.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023CrossRefPubMed Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023CrossRefPubMed
4.
Zurück zum Zitat Stinton LM, Loomba R (2014) Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 60:5–13PubMed Stinton LM, Loomba R (2014) Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 60:5–13PubMed
5.
Zurück zum Zitat Fernandez-Salazar L, Velayos B, Aller R, Lozano F, Garrote JA, Gonzalez JM (2011) Percutaneous liver biopsy: patients’ point of view. Scand J Gastroenterol 46:727–731CrossRefPubMed Fernandez-Salazar L, Velayos B, Aller R, Lozano F, Garrote JA, Gonzalez JM (2011) Percutaneous liver biopsy: patients’ point of view. Scand J Gastroenterol 46:727–731CrossRefPubMed
7.
Zurück zum Zitat Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618CrossRefPubMed Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618CrossRefPubMed
8.
Zurück zum Zitat Bedogni G, Nobili V, Tiribelli C (2014) Epidemiology of fatty liver: an update. World J Gastroenterol 20:9050–9054PubMedPubMedCentral Bedogni G, Nobili V, Tiribelli C (2014) Epidemiology of fatty liver: an update. World J Gastroenterol 20:9050–9054PubMedPubMedCentral
9.
Zurück zum Zitat Idilman IS, Keskin O, Celik A et al (2016) A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol 57:271–278CrossRefPubMed Idilman IS, Keskin O, Celik A et al (2016) A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol 57:271–278CrossRefPubMed
10.
Zurück zum Zitat Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425CrossRefPubMed Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425CrossRefPubMed
11.
Zurück zum Zitat Hamilton G, Yokoo T, Bydder M et al (2011) In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed 24:784–790 Hamilton G, Yokoo T, Bydder M et al (2011) In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed 24:784–790
12.
Zurück zum Zitat Meisamy S, Hines CDG, Hamilton G et al (2011) Quantification of hepatic steatosis with T1-independent, T2*-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258:767–775CrossRefPubMedPubMedCentral Meisamy S, Hines CDG, Hamilton G et al (2011) Quantification of hepatic steatosis with T1-independent, T2*-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258:767–775CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Kim KY, Song JS, Kannengiesser S, Han YM (2015) Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area. Radiol Med 120:1083–1093CrossRefPubMed Kim KY, Song JS, Kannengiesser S, Han YM (2015) Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area. Radiol Med 120:1083–1093CrossRefPubMed
14.
Zurück zum Zitat Motosugi U, Hernando D, Bannas P et al (2015) Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI. J Magn Reson Imaging 42:1241–1248CrossRefPubMedPubMedCentral Motosugi U, Hernando D, Bannas P et al (2015) Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI. J Magn Reson Imaging 42:1241–1248CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Rehm JL, Wolfgram PM, Hernando D, Eickhoff JC, Allen DB, Reeder SB (2015) Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 25:2921–2930CrossRefPubMedPubMedCentral Rehm JL, Wolfgram PM, Hernando D, Eickhoff JC, Allen DB, Reeder SB (2015) Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 25:2921–2930CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hetterich H, Bayerl C, Peters A et al (2016) Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population. Eur Radiol 26:1895–1904CrossRefPubMed Hetterich H, Bayerl C, Peters A et al (2016) Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population. Eur Radiol 26:1895–1904CrossRefPubMed
17.
Zurück zum Zitat Park CC, Hooker C, Hooker JC et al (2018) Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range. J Magn Reson Imaging. https://doi.org/10.1002/jmri.26168 Park CC, Hooker C, Hooker JC et al (2018) Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range. J Magn Reson Imaging. https://​doi.​org/​10.​1002/​jmri.​26168
18.
Zurück zum Zitat Bonekamp S, Tang A, Mashhood A et al (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39:1525–1532CrossRefPubMedPubMedCentral Bonekamp S, Tang A, Mashhood A et al (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39:1525–1532CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Angulo P (2006) Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl 12:523–534CrossRefPubMed Angulo P (2006) Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl 12:523–534CrossRefPubMed
20.
Zurück zum Zitat Middleton MS, Van Natta ML, Heba ER et al (2018) Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology 67:858–872CrossRefPubMed Middleton MS, Van Natta ML, Heba ER et al (2018) Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology 67:858–872CrossRefPubMed
21.
Zurück zum Zitat Park CC, Phirum N, Hernandez C et al (2017) Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152:598–607CrossRefPubMed Park CC, Phirum N, Hernandez C et al (2017) Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152:598–607CrossRefPubMed
22.
Zurück zum Zitat Paige JS, Bernstein GS, Heba E et al (2017) A pilo comparative study of quantitative ultrasound, conventional ultrasound, and MRI for predicting histology-determined steatosis grade in adult nonalcoholic fatty liver disease. AJR Am J Roentgenol 208:W168–W177CrossRefPubMedPubMedCentral Paige JS, Bernstein GS, Heba E et al (2017) A pilo comparative study of quantitative ultrasound, conventional ultrasound, and MRI for predicting histology-determined steatosis grade in adult nonalcoholic fatty liver disease. AJR Am J Roentgenol 208:W168–W177CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753–761CrossRefPubMed Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753–761CrossRefPubMed
24.
Zurück zum Zitat Schwimmer JB, Middleton MS, Behling C et al (2015) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61:1887–1895CrossRefPubMed Schwimmer JB, Middleton MS, Behling C et al (2015) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61:1887–1895CrossRefPubMed
25.
Zurück zum Zitat Paparo F, Cenderello G, Revelli M et al (2015) Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis. Biomed Res Int 2015:758164CrossRefPubMedPubMedCentral Paparo F, Cenderello G, Revelli M et al (2015) Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis. Biomed Res Int 2015:758164CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Chiang HJ, Lin LH, Li CW et al (2014) Magnetic resonance fat quantification in living donor liver transplantation. Transplant Proc 46:666–668CrossRefPubMed Chiang HJ, Lin LH, Li CW et al (2014) Magnetic resonance fat quantification in living donor liver transplantation. Transplant Proc 46:666–668CrossRefPubMed
27.
Zurück zum Zitat Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422–431CrossRefPubMedPubMedCentral Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422–431CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767–775CrossRefPubMed Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767–775CrossRefPubMed
29.
Zurück zum Zitat Kuhn JP, Hernando D, Munoz del Rio A et al (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 265:133–142CrossRefPubMedPubMedCentral Kuhn JP, Hernando D, Munoz del Rio A et al (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 265:133–142CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Joe E, Lee JM, Kim KW et al (2012) Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2corrected chemical shift MRI. J Magn Reson Imaging 36:1124–1130CrossRefPubMed Joe E, Lee JM, Kim KW et al (2012) Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2corrected chemical shift MRI. J Magn Reson Imaging 36:1124–1130CrossRefPubMed
31.
Zurück zum Zitat Zand KA, Shah A, Heba E et al (2015) Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. J Magn Reson Imaging 42:1223–1232CrossRefPubMedPubMedCentral Zand KA, Shah A, Heba E et al (2015) Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. J Magn Reson Imaging 42:1223–1232CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Heba ER, Desai A, Zand KA et al (2016) Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging 43:398–406CrossRefPubMed Heba ER, Desai A, Zand KA et al (2016) Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging 43:398–406CrossRefPubMed
33.
Zurück zum Zitat Yokoo T, Serai SD, Pirasteh A et al (2018) Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286:486–498CrossRefPubMed Yokoo T, Serai SD, Pirasteh A et al (2018) Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286:486–498CrossRefPubMed
34.
Zurück zum Zitat Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRefPubMed Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRefPubMed
35.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed
37.
38.
Zurück zum Zitat Egger M, Juni P, Bartlett C, Holenstein F, Sterne J (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess Rep 7:1–76 Egger M, Juni P, Bartlett C, Holenstein F, Sterne J (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess Rep 7:1–76
39.
Zurück zum Zitat Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31CrossRefPubMedPubMedCentral Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990CrossRefPubMed Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990CrossRefPubMed
41.
Zurück zum Zitat Cronin P, Kelly AM, Altaee D, Foerster B, Petrou M, Dwamena BA (2018) How to perform a systematic review and meta-analysis of diagnostic imaging studies. Acad Radiol 25:573–593CrossRefPubMed Cronin P, Kelly AM, Altaee D, Foerster B, Petrou M, Dwamena BA (2018) How to perform a systematic review and meta-analysis of diagnostic imaging studies. Acad Radiol 25:573–593CrossRefPubMed
42.
Zurück zum Zitat Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293–1316CrossRefPubMed Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293–1316CrossRefPubMed
43.
Zurück zum Zitat Dukic V, Gatsonis C (2003) Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds. Biometrics 59:936–946CrossRefPubMed Dukic V, Gatsonis C (2003) Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds. Biometrics 59:936–946CrossRefPubMed
44.
Zurück zum Zitat Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893CrossRefPubMed Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893CrossRefPubMed
45.
Zurück zum Zitat Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87–97CrossRefPubMed Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87–97CrossRefPubMed
46.
Zurück zum Zitat Deng J, Fishbein MH, Rigsby CK, Zhang G, Schoeneman SE, Donaldson JS (2014) Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease. Pediatr Radiol 44:1379–1387CrossRefPubMed Deng J, Fishbein MH, Rigsby CK, Zhang G, Schoeneman SE, Donaldson JS (2014) Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease. Pediatr Radiol 44:1379–1387CrossRefPubMed
47.
Zurück zum Zitat Idilman IS, Keskin O, Elhan AH, Idilman R, Karcaaltincaba M (2014) Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. Scand J Gastroenterol 49:617–624CrossRefPubMed Idilman IS, Keskin O, Elhan AH, Idilman R, Karcaaltincaba M (2014) Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. Scand J Gastroenterol 49:617–624CrossRefPubMed
48.
Zurück zum Zitat Joy TR, McKenzie CA, Tirona RG et al (2017) Sitagliptin in patients with non-alcoholic steatohepatitis: a randomized, placebo-controlled trial. World J Gastroenterol 23:141–150CrossRefPubMedPubMedCentral Joy TR, McKenzie CA, Tirona RG et al (2017) Sitagliptin in patients with non-alcoholic steatohepatitis: a randomized, placebo-controlled trial. World J Gastroenterol 23:141–150CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Kukuk GM, Hittatiya K, Sprinkart AM et al (2015) Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol 25:2869–2879CrossRefPubMed Kukuk GM, Hittatiya K, Sprinkart AM et al (2015) Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol 25:2869–2879CrossRefPubMed
50.
Zurück zum Zitat Loomba R, Sirlin CB, Ang B et al (2015) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61:1239–1250CrossRefPubMed Loomba R, Sirlin CB, Ang B et al (2015) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61:1239–1250CrossRefPubMed
51.
Zurück zum Zitat Cui J, Philo L, Nguyen P et al (2016) Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 65:369–376CrossRefPubMedPubMedCentral Cui J, Philo L, Nguyen P et al (2016) Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 65:369–376CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Caussy C, Alquiraish MH, Nguyen P et al (2018) Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 67:1348–1359CrossRefPubMed Caussy C, Alquiraish MH, Nguyen P et al (2018) Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 67:1348–1359CrossRefPubMed
53.
Zurück zum Zitat Jayakumar S, Middleton MS, Lawitz EJ et al (2019) Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of selonsertib. J Hepatol 70:133–141CrossRefPubMed Jayakumar S, Middleton MS, Lawitz EJ et al (2019) Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of selonsertib. J Hepatol 70:133–141CrossRefPubMed
54.
Zurück zum Zitat Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906CrossRefPubMed Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906CrossRefPubMed
55.
Zurück zum Zitat Tyagi A, Yeganeh O, Levin Y et al (2015) Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. Abdom Imaging 40:3070–3077CrossRefPubMedPubMedCentral Tyagi A, Yeganeh O, Levin Y et al (2015) Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. Abdom Imaging 40:3070–3077CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Yokoo T, Shiehmorteza M, Hamilton G et al (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749–759CrossRefPubMedPubMedCentral Yokoo T, Shiehmorteza M, Hamilton G et al (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749–759CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Tian F, Shen G, Deng Y, Diao W, Jia Z (2017) The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review. Eur Radiol 4786–4796. https://doi.org/10.1007/s00330-017-4831-y Tian F, Shen G, Deng Y, Diao W, Jia Z (2017) The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review. Eur Radiol 4786–4796. https://​doi.​org/​10.​1007/​s00330-017-4831-y
58.
Zurück zum Zitat Hernaez R, Lazo M, Bonekamp S et al (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082–1090CrossRefPubMed Hernaez R, Lazo M, Bonekamp S et al (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082–1090CrossRefPubMed
59.
Zurück zum Zitat Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Pomper MG (2012) Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis. Acad Radiol 19:1075–1086CrossRefPubMedPubMedCentral Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Pomper MG (2012) Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis. Acad Radiol 19:1075–1086CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y (2010) Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C (eds) Cochrane handbook for systematic reviews of diagnostic test accuracy Version 1.0. The Cochrane Collaboration. Available via http://srdta.cochrane.org/. Accessed 21 June 2018 Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y (2010) Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C (eds) Cochrane handbook for systematic reviews of diagnostic test accuracy Version 1.0. The Cochrane Collaboration. Available via http://​srdta.​cochrane.​org/​. Accessed 21 June 2018
Metadaten
Titel
Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis
verfasst von
Yali Qu
Mou Li
Gavin Hamilton
Yingzhen N. Zhang
Bin Song
Publikationsdatum
15.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 10/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06071-5

Weitere Artikel der Ausgabe 10/2019

European Radiology 10/2019 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.